![Matthew J. Giacalone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew J. Giacalone
Chief Operating Officer at Vaxiion Therapeutics, Inc.
Profile
Dr. Matthew J.
Giacalone is Vice President-Development & Research at Vaxiion Therapeutics, Inc.
He received his undergraduate degree from San Diego State University, an MBA from the University of California, San Diego, and a doctorate degree from San Diego State University.
Matthew J. Giacalone active positions
Companies | Position | Start |
---|---|---|
Vaxiion Therapeutics, Inc.
![]() Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Chief Operating Officer | - |
Training of Matthew J. Giacalone
San Diego State University | Doctorate Degree |
University of California San Diego | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Vaxiion Therapeutics, Inc.
![]() Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Matthew J. Giacalone